Citation only
via OpenAlex
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Abdel Ali Belaidi, Ashley Ian Bush
Journal of Neurochemistry · 2015 · ▲ 578 citations
Abstract
Brain iron homeostasis is increasingly recognized as a potential target for the development of drug therapies for aging-related disorders. Dysregulation of iron metabolism associated with cellular damage and oxidative stress is reported as a common event in several neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases. Indeed, many proteins initially characterized in those diseases such as amyloid-β protein, α-synuclein, and huntingtin have been linked to iron neurochemistry. Iron plays a crucial role in maintaining normal physiological functions in the brain through its participation in many cellular functions such as mitochondrial respiration, myelin synthesis, and neurotransmitter synthesis and metabolism. However, excess iron is a potent source of oxidative damage through radical formation and because of the lack of a body-wide export system, a tight regulation of its uptake, transport and storage is crucial in fulfilling cellular functions while keeping its level below the toxicity threshold. In this review, we discuss the current knowledge on iron homeostasis in the brain and explore how alterations in brain iron metabolism affect neuronal function with emphasis on iron dysregulation in Alzheimer's and Parkinson's diseases. Finally, we discuss recent findings implicating iron as a diagnostic and therapeutic target for Alzheimer's and Parkinson's diseases. Iron plays a fundamental role in maintaining the high metabolic and energetic requirements of the brain. However, iron has to be maintained in a delicate balance as both iron overload and iron deficiency are detrimental to the brain and can trigger neurodegeneration. Here, we discuss the current knowledge on brain iron homeostasis and its involvement in major aging-related neurodegenerative diseases. This article is part of a special issue on Parkinson disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jnc.13425
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Belaidi, A.A., & Bush, A.I. (2015). Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. <em>Journal of Neurochemistry</em>. https://doi.org/10.1111/jnc.13425
Vancouver
Belaidi AA, Bush AI. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. Journal of Neurochemistry. 2015. doi:10.1111/jnc.13425.
BibTeX
@article{abdel2015Ironne,
title = {Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics},
author = {Abdel Ali Belaidi and Ashley Ian Bush},
journal = {Journal of Neurochemistry},
year = {2015},
doi = {10.1111/jnc.13425},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Alzheimer s Disease 2009
Citation only
Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
Neuromolecular medicine 2026
Open access · OA
SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential.
Oxidative Medicine and Cellular Longevity 2020
Open access · CC-BY
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
Current Neuropharmacology 2009
Open access · OA
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018
Open access · OA
Role of iron metabolism in heart failure: From iron deficiency to iron overload
Cell Death Discovery 2025
Open access · CC-BY